These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3521248)

  • 1. Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications.
    Steiner G
    Am J Cardiol; 1986 May; 57(14):27G-30G. PubMed ID: 3521248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.
    Steiner G; Vranic M
    Int J Obes; 1982; 6 Suppl 1():117-24. PubMed ID: 6749716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglycerides and atherogenic lipoproteins: rationale for lipid management.
    Krauss RM
    Am J Med; 1998 Jul; 105(1A):58S-62S. PubMed ID: 9707269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in very low density lipoprotein particle size and production in response to sucrose feeding and hyperinsulinemia.
    Kazumi T; Vranic M; Steiner G
    Endocrinology; 1985 Sep; 117(3):1145-50. PubMed ID: 4017959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-fat, high-carbohydrate diets and atherogenic risk.
    Baum CL; Brown M
    Nutr Rev; 2000 May; 58(5):148-51. PubMed ID: 10860395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia in diabetes mellitus.
    Yoshino G; Hirano T; Kazumi T
    Diabetes Res Clin Pract; 1996 Jun; 33(1):1-14. PubMed ID: 8877270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic hypertriglyceridemia: evidence for three clinical syndromes.
    Reaven GM; Greenfield MS
    Diabetes; 1981; 30(Suppl 2):66-75. PubMed ID: 7028540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertriglyceridemia: danger for the arteries].
    Chanu B
    Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenicity of triglyceride-rich lipoproteins.
    Krauss RM
    Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.
    Reaven GM
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):49-62. PubMed ID: 15752921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative and qualitative alterations of plasma lipoproteins in obesity].
    Nakao Y; Kageyama A; Ikeda K; Satou A; Asakura Y; Hirose J; Suzuki M; Tsushima M; Harano Y
    Nihon Naibunpi Gakkai Zasshi; 1993 Aug; 69(7):670-80. PubMed ID: 8375554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical and morphologic study of very low density lipoproteins in carbohydrate-induced hypertriglyceridemia.
    Ruderman NB; Jones AL; Krauss RM; Shafrir E
    J Clin Invest; 1971 Jun; 50(6):1355-68. PubMed ID: 5578237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.